Chargement en cours...
Model‐Based Selection and Recommendation for Subcutaneous Abatacept Dose in Patients With Polyarticular Juvenile Idiopathic Arthritis
The selective T‐cell costimulation modulator abatacept is approved for treatment of adult rheumatoid arthritis (RA) and polyarticular juvenile idiopathic arthritis (pJIA; 6‐17 years [intravenous] and 2‐17 years [subcutaneous]). An extrapolation approach was taken to determine subcutaneous weight‐tie...
Enregistré dans:
| Publié dans: | J Clin Pharmacol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8048692/ https://ncbi.nlm.nih.gov/pubmed/33284480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.1797 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|